Fri, September 14, 2018
Thu, September 13, 2018
Wed, September 12, 2018
Tue, September 11, 2018
Mon, September 10, 2018
Fri, September 7, 2018
Thu, September 6, 2018
Wed, September 5, 2018
Tue, September 4, 2018
Fri, August 31, 2018
Thu, August 30, 2018
Wed, August 29, 2018
Tue, August 28, 2018
Mon, August 27, 2018
Fri, August 24, 2018
Thu, August 23, 2018
Wed, August 22, 2018
Tue, August 21, 2018
Mon, August 20, 2018
Fri, August 17, 2018

Adam Walsh Maintained (ASND) at Strong Buy with Decreased Target to $81 on, Aug 30th, 2018

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-decreased-target-to-81-on-aug-30th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Adam Walsh of Stifel, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $85 to $81 on, Aug 30th, 2018.

Adam has made no other calls on ASND in the last 4 months.



There is 1 other peer that has a rating on ASND. Out of the 1 peers that are also analyzing ASND, 0 agree with Adam's Rating of Hold.



This is the rating of the analyst that currently disagrees with Adam


  • Michelle Gilson of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $81 on, Tuesday, August 7th, 2018